Biogen Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Biogen has a total shareholder equity of $16.4B and total debt of $6.3B, which brings its debt-to-equity ratio to 38.5%. Its total assets and total liabilities are $28.3B and $12.0B respectively. Biogen's EBIT is $2.3B making its interest coverage ratio 11.9. It has cash and short-term investments of $1.7B.
Informazioni chiave
38.5%
Rapporto debito/patrimonio netto
US$6.29b
Debito
| Indice di copertura degli interessi | 11.9x |
| Contanti | US$1.70b |
| Patrimonio netto | US$16.36b |
| Totale passività | US$11.95b |
| Totale attività | US$28.31b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 0R1B's short term assets ($6.8B) exceed its short term liabilities ($5.4B).
Passività a lungo termine: 0R1B's short term assets ($6.8B) exceed its long term liabilities ($6.5B).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 0R1B's net debt to equity ratio (28.1%) is considered satisfactory.
Riduzione del debito: 0R1B's debt to equity ratio has reduced from 42.5% to 38.5% over the past 5 years.
Copertura del debito: 0R1B's debt is well covered by operating cash flow (33.8%).
Copertura degli interessi: 0R1B's interest payments on its debt are well covered by EBIT (11.9x coverage).